Search for: "Watson Pharma Inc." Results 21 - 40 of 116
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2014, 9:05 pm by Patent Docs
Watson Laboratories Inc. et al. 1:14-cv-01051; filed August 15, 2014 in the District Court of Delaware • Plaintiff: AstraZeneca AB • Defendants: Watson Laboratories Inc.; Actavis Inc.; Actavis LLC Infringement of U.S. [read post]
17 Aug 2014, 9:59 pm by Patent Docs
Watson Laboratories Inc. 1:14-cv-01003; filed July 31, 2014 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals LLC; Besins Healthcare Luxemborg SARL • Defendant: Watson Laboratories Inc. [read post]
24 Jun 2014, 9:59 pm by Patent Docs
• Defendants: Actavis Laboratories FL Inc.; Actavis Inc.; Actavis Pharma Inc.; Watson Laboratories Inc. [read post]
10 Jun 2014, 5:25 pm by Lawrence B. Ebert
ApotexApotex Inc., Apotex Corp., Sandoz, Inc., Hit-TechPharmacal Co., Inc., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
2 Mar 2014, 8:47 pm by Patent Docs
• Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
17 Nov 2013, 8:56 pm by Patent Docs
• Defendants: Watson Laboratories Inc; Actavis, Inc.; Actavis Pharma, Inc. [read post]
15 Sep 2013, 9:42 pm by Patent Docs
• Defendant: Watson Laboratories Inc. [read post]
16 Jun 2013, 9:32 pm by Patent Docs
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
24 Mar 2013, 8:01 pm by Patent Docs
– Florida; Watson Pharma, Inc.; Actavis, Inc. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
21 Feb 2013, 12:00 am
Watson Pharma., Inc. , the Federal Circuit Court of Appeals reversed a district court’s holding of invalidity for lack of enablement stating, “Watson failed as a matter of law to show with clear and convincing evidence that Cephalon’s patents require undue experimentation to practice the invention. [read post]
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
15 Jan 2013, 11:33 am by Ed Silverman
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
13 Jan 2013, 9:06 pm by Patent Docs
• Defendants: Apotex Inc.; Apotex Corp.; Sandoz, Inc.; Hi-Tech Pharmacal Co., Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]